Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), Philadelphia, PA – FDA Inspections
Inspection records and compliance data for Jazz Pharmaceuticals, Inc. in Philadelphia, Pennsylvania. 2 FDA inspections on record, last inspected July 15, 2024. Publicly traded as NASDAQ: JAZZ.
This profile covers Jazz Pharmaceuticals, Inc. based in Philadelphia, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 28, 2024. Last inspected July 15, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 15, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1245337 |
| February 28, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1232998 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Jazz Pharmaceuticals, Inc.
Stock ticker
JAZZ
Exchange
NASDAQ
Share price
$227.19
Market cap
$14.6B
Price as of
November 6, 2026
FEI Number
3026568801
Address
2005 Market St Ste 2100, Philadelphia, Pennsylvania 19103, United States
Country
United States
ID: 5282d838-1f97-4609-a024-4a7e15194887